Top-News

Sophiris Bio News

Keine aktuellen Kursdaten verfügbar
WKN: A1JWLP
ISIN: CA83578Q1000
Typ: Aktie

Sophiris Bio News

12.11.12 - PR Newswire
Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights
Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights PR Newswire
06.11.12 - PR Newswire
Sophiris Bio to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Sophiris Bio to Present at the Lazard Capital Markets 9th Annual Healthcare Conference PR Newswire
09.10.12 - PR Newswire
Sophiris Bio Announces 12 Month Follow-Up Data from Phase 2b TRIUMPH Clinical Trial of PRX302 in Patients with Benign Prostatic Hyperplasia
Sophiris Bio Announces 12 Month Follow-Up Data from Phase 2b TRIUMPH Clinical Trial of PRX302 in Patients with Benign Prostatic Hyperplasia PR Newswire
02.10.12 - PR Newswire
Alimera Sciences Closes $40 Million Financing
Alimera Sciences Closes $40 Million Financing Stockholders Approve the Issuance of Series A Preferred Stock and Warrants PR Newswire
02.10.12 - PR Newswire
Sophiris Bio to Present at the 11th Annual BIO Investor Forum
Sophiris Bio to Present at the 11th Annual BIO Investor Forum PR Newswire
31.08.12 - PR Newswire
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration PR Newswire
11.01.10 - Dow Jones
DJ IRW-PRESS: Protox Therapeutics Inc.: Protox -2-
DJ IRW-PRESS: Protox Therapeutics Inc.: Protox meldet positive Phase-2b-​BPH-Ergebnisse Protox meldet positive Phase-2b-​BPH-Ergebnisse Vancouver, 11. Januar (CNW). ...
11.01.10 - Dow Jones
DJ IRW-PRESS: Protox Therapeutics Inc.: Protox meldet positive Phase-2b-BPH-Ergebnisse
DJ IRW-PRESS: Protox Therapeutics Inc.: Protox meldet positive Phase-2b-​BPH-Ergebnisse Protox meldet positive Phase-2b-​BPH-Ergebnisse Vancouver, 11. Januar (CNW). ...
21.10.08 - Aktiencheck
Protox Therapeutics grotesk unterbewertet - Global Biotech Investing
13.10.08 - Aktiencheck
Protox Therapeutics für mutige Spekulanten - Hot Stocks Investor

Newssuche

Videos

newspaper
26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »